Status | Study |
NOT_YET_RECRUITING |
Study Name: Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis Condition: Myasthenia Gravis Date: 2023-10-24 Interventions: CNP-106 is comprised of an antigenic AChR Peptide Pool (~1 ?g of each AChR? and AChR? peptide comprising AChR Peptide Pool Drug Substance per mg parti |
Completed |
Study Name: Influences of Sugammadex on Postoperative Progress in Patients With Myasthenia Gravis Undergoing Video-assisted Thoracoscopic Thymectomy: Retrospective Study Condition: Myasthenia Gravis Date: 2023-01-12 Interventions: Not Provided |
RECRUITING |
Study Name: The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis Condition: Myasthenia Gravis Date: 2022-09-27 Interventions: ME&MG is a standalone software (digital solution) running on patients smartphones, connected to a web portal for physicians.It is intended t |
RECRUITING |
Study Name: Descriptive Analysis of Real-world Data Collected With ME&MGopen Condition: Myasthenia Gravis Date: 2022-09-07 Interventions: Smartphone application includes digital tests and e-questionnaires |
Recruiting |
Study Name: Trial of Orencia in Patients With Myasthenia Gravis Condition: Myasthenia Gravis Date: 2017-02-17 Interventions: Drug: Abatacept Injection Subcutaneous administration of abatacept |
Recruiting |
Study Name: Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis. Condition: Myasthenia Gravis Date: 2017-02-10 Interventions: Drug: UCB7665 UCB7665 will be |
Active, not recruiting |
Study Name: Tissue Repository for Studies of Myasthenia Gravis Condition: Myasthenia Gravis Date: 2016-09-12 Interventions: Other: No interventions |
Active, not recruiting |
Study Name: Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis Condition: Myasthenia Gravis Date: 2015-11-13 Interventions: Biological: CV-MG01 |
Recruiting |
Study Name: Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis Condition: Myasthenia Gravis, Generalized Date: 2015-06-23 Interventions: Drug: Placebo Drug: CFZ533 |
Recruiting |
Study Name: Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis Condition: Myasthenia Gravis Date: 2015-06-14 Interventions: Drug: IGIV-C |